May 12, 2025
Jefferson Shreve- Amount
- $15,001 to $50,000
- Filed
- Jun 22, 2025
Congress ticker disclosure profile
As of August 1 at 7:10 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference RPD. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
3
Disclosed ranges
$146K
Most active member desks
6 buys vs 4 sells
Latest trade May 12, 2025
May 12, 2025
Jefferson ShreveApr 7, 2025
Jefferson ShreveMar 31, 2025
Jefferson ShreveFeb 24, 2025
Jefferson ShreveMay 15, 2024
Josh GottheimerAug 10, 2022
Josh GottheimerNov 24, 2020
Gilbert CisnerosMar 10, 2020
Gilbert CisnerosFeb 21, 2020
Gilbert CisnerosFeb 14, 2020
Josh Gottheimer| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| May 12, 2025 | Jefferson Shreve | Sell | $15,001 to $50,000 | Jun 22, 2025 | Open card |
| Apr 7, 2025 | Jefferson Shreve | Buy | $15,001 to $50,000 | May 8, 2025 | Open card |
| Mar 31, 2025 | Jefferson Shreve | Buy | $15,001 to $50,000 | Apr 11, 2025 | Open card |
| Feb 24, 2025 | Jefferson Shreve | Sell | $15,001 to $50,000 | Mar 9, 2025 | Open card |
| May 15, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Jun 8, 2024 | Open card |
| Aug 10, 2022 | Josh Gottheimer | Sell | $1,001 to $15,000 | Sep 16, 2022 | Open card |
| Nov 24, 2020 | Gilbert Cisneros | Buy | Receipt pending ingestion | Dec 15, 2020 | Open card |
| Mar 10, 2020 | Gilbert Cisneros | Buy | Receipt pending ingestion | Apr 16, 2020 | Open card |
| Feb 21, 2020 | Gilbert Cisneros | Buy | Receipt pending ingestion | Mar 10, 2020 | Open card |
| Feb 14, 2020 | Josh Gottheimer | Buy | Receipt pending ingestion | Mar 16, 2020 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 6 of 10 filed rows include disclosed amount ranges (60%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.